|
US20050119251A1
(en)
*
|
2001-12-21 |
2005-06-02 |
Jian-Min Fu |
Nicotinamide derivatives and their use as therapeutic agents
|
|
DE10217006A1
(de)
*
|
2002-04-16 |
2003-11-06 |
Merck Patent Gmbh |
Substituierte Indole
|
|
DE10259244A1
(de)
*
|
2002-12-17 |
2004-07-01 |
Merck Patent Gmbh |
N-(Indolethyl-)cycloamin-Verbindungen
|
|
AU2003289904B2
(en)
*
|
2002-12-20 |
2009-12-10 |
Merck Patent Gmbh |
Substituted benzodioxepins
|
|
PT1701940E
(pt)
*
|
2003-12-23 |
2008-07-30 |
Lundbeck & Co As H |
Derivados de 2-(1h-indolilsulfanil)-benzil-amina como ssri
|
|
AR052308A1
(es)
*
|
2004-07-16 |
2007-03-14 |
Lundbeck & Co As H |
Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
|
|
EP2248524A3
(en)
|
2004-08-25 |
2011-03-09 |
Takeda Pharmaceutical Company Limited |
Preventives/remedies for stress urinary incontinence and method of screening the same
|
|
EP1799667B1
(en)
|
2004-09-20 |
2013-03-20 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as therapeutic agents
|
|
CA2580845A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
|
|
EP1804799B1
(en)
|
2004-09-20 |
2013-08-21 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
|
CA2580856A1
(en)
*
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
|
CN101084212A
(zh)
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
|
|
EP1830837B1
(en)
|
2004-09-20 |
2013-09-04 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
|
|
CN101083986A
(zh)
*
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
双环杂环衍生物及其作为硬脂酰CoA去饱和酶(SCD)抑制剂的用途
|
|
CA2580855A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
|
TW200630337A
(en)
*
|
2004-10-14 |
2006-09-01 |
Euro Celtique Sa |
Piperidinyl compounds and the use thereof
|
|
ES2346335T3
(es)
*
|
2005-01-07 |
2010-10-14 |
F. Hoffmann-La Roche Ag |
Derivados de (4-(heteroaril)piperacin-1-il)-(fenil 2,5-sustituido)metanona como inhibidores del transportador de glicina 1 (glyt-1) para el tratamiento de trastornos neurologicos e neuropsiquiatricos.
|
|
DE102005019670A1
(de)
*
|
2005-04-26 |
2006-11-02 |
Merck Patent Gmbh |
Verfahren zur Herstellung von (5-(4-[4-(5-Cyano-3-indolyl)-butyl)-1-piperazinyl)-benzofuran-2-carboxamid
|
|
MX2007015216A
(es)
*
|
2005-06-03 |
2008-02-22 |
Xenon Pharmaceuticals Inc |
Derivados de aminotiazol y sus usos como agentes terapeuticos.
|
|
TW200800959A
(en)
|
2005-06-10 |
2008-01-01 |
Wyeth Corp |
Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
|
|
EP1893617A1
(en)
|
2005-06-17 |
2008-03-05 |
Wyeth a Corporation of the State of Delaware |
Tricyclic compounds useful as serotonin inhibitors and 5-ht1a agonists and antagonists
|
|
AR054393A1
(es)
*
|
2005-06-17 |
2007-06-20 |
Lundbeck & Co As H |
Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
|
|
US7629473B2
(en)
*
|
2005-06-17 |
2009-12-08 |
H. Lundbeck A/S |
2-(1H-indolylsulfanyl)-aryl amine derivatives
|
|
US7994331B2
(en)
|
2005-07-13 |
2011-08-09 |
Msd K.K. |
Heterocycle-substituted benzimidazole derivative
|
|
RU2008127501A
(ru)
*
|
2006-01-13 |
2010-02-20 |
Вайет (Us) |
Сульфонилзамещенные 1н-индолы в качастве лигандов 5-гидрокситриптаминовых рецепторов
|
|
WO2007110449A1
(en)
*
|
2006-03-29 |
2007-10-04 |
Euro-Celtique S.A. |
Benzenesulfonamide compounds and their use
|
|
WO2007118854A1
(en)
*
|
2006-04-13 |
2007-10-25 |
Euro-Celtique S.A. |
Benzenesulfonamide compounds and the use thereof
|
|
US8791264B2
(en)
*
|
2006-04-13 |
2014-07-29 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and their use as blockers of calcium channels
|
|
US8158617B2
(en)
|
2006-05-16 |
2012-04-17 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound and use thereof
|
|
WO2008015516A1
(en)
*
|
2006-07-28 |
2008-02-07 |
Pfizer Products Inc. |
Fused tricyclic heterocycles for the treatment of schizophrenia
|
|
US8399486B2
(en)
|
2007-04-09 |
2013-03-19 |
Purdue Pharma L.P. |
Benzenesulfonyl compounds and the use thereof
|
|
JP2010527915A
(ja)
*
|
2007-04-26 |
2010-08-19 |
アバロン ファーマシューティカルズ，インコーポレイテッド |
多重環化合物及びその用途
|
|
CA2691450A1
(en)
|
2007-08-22 |
2009-02-26 |
Abbott Gmbh & Co. Kg |
4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy
|
|
WO2009040659A2
(en)
*
|
2007-09-28 |
2009-04-02 |
Purdue Pharma L.P. |
Benzenesulfonamide compounds and the use thereof
|
|
EP2216023A4
(en)
|
2007-11-15 |
2013-03-13 |
Takeda Pharmaceutical |
CONDENSED PYRIDINE DERIVATIVE AND ITS USE
|
|
EP2250162B1
(en)
|
2008-02-07 |
2014-03-19 |
AbbVie Inc. |
Amide derivatives as positive allosteric modulators and methods of use thereof
|
|
MX2010010773A
(es)
|
2008-04-01 |
2011-04-11 |
Abbott Gmbh & Co Kg |
Tetrahidroisoquinolinas, composiciones farmaceuticas que las contienen y su uso en terapia.
|
|
GB0813144D0
(en)
|
2008-07-17 |
2008-08-27 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0813142D0
(en)
|
2008-07-17 |
2008-08-27 |
Glaxo Group Ltd |
Novel compounds
|
|
CN102498095A
(zh)
*
|
2009-02-05 |
2012-06-13 |
国立大学法人京都大学 |
二氢吲哚衍生物
|
|
AR075442A1
(es)
|
2009-02-16 |
2011-03-30 |
Abbott Gmbh & Co Kg |
Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
|
|
TW201038569A
(en)
|
2009-02-16 |
2010-11-01 |
Abbott Gmbh & Co Kg |
Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
|
|
CA2759187A1
(en)
*
|
2009-04-03 |
2010-10-07 |
Medisyn Technologies, Inc. |
Compositions for treatment of alzheimer's disease
|
|
CA2770724A1
(en)
*
|
2009-08-10 |
2011-02-17 |
Galenea Corporation |
5-ht inhibiting indole compounds
|
|
TWI535440B
(zh)
*
|
2009-10-26 |
2016-06-01 |
Ｌｇ生命科學有限公司 |
包括吲哚化合物之醫藥組成物
|
|
JPWO2011071136A1
(ja)
|
2009-12-11 |
2013-04-22 |
アステラス製薬株式会社 |
線維筋痛症治療剤
|
|
ES2533990T3
(es)
*
|
2010-02-24 |
2015-04-16 |
Research Triangle Institute |
Antagonistas de receptores opioides de arilpiperazina
|
|
WO2012014127A1
(en)
|
2010-07-30 |
2012-02-02 |
Ranbaxy Laboratories Limited |
5-lipoxygenase inhibitors
|
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9045459B2
(en)
|
2010-08-13 |
2015-06-02 |
AbbVie Deutschland GmbH & Co. KG |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US8877794B2
(en)
|
2010-08-13 |
2014-11-04 |
Abbott Laboratories |
Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
PL395470A1
(pl)
|
2011-06-29 |
2013-01-07 |
Adamed Spólka Z Ograniczona Odpowiedzialnoscia |
Sulfonamidowe pochodne amin alicyklicznych do leczenia chorób osrodkowego ukladu nerwowego
|
|
TW201319049A
(zh)
|
2011-08-05 |
2013-05-16 |
Abbott Gmbh & Co Kg |
胺基□唍、胺基硫□唍及胺基－１，２，３，４－四氫喹啉衍生物，包含彼等之醫藥組合物及彼等於治療之用途
|
|
CN104011028A
(zh)
|
2011-11-18 |
2014-08-27 |
艾伯维德国有限责任两合公司 |
N-取代的氨基苯并环庚烯、氨基四氢化萘、氨基茚满和苯烷基胺衍生物、包含所述衍生物的药物组合物及其在治疗中的用途
|
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9656955B2
(en)
|
2013-03-15 |
2017-05-23 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9650334B2
(en)
|
2013-03-15 |
2017-05-16 |
Abbvie Inc. |
Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
JO3425B1
(ar)
|
2013-07-15 |
2019-10-20 |
Novartis Ag |
مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
|
|
CN105992764A
(zh)
|
2013-10-17 |
2016-10-05 |
艾伯维德国有限责任两合公司 |
氨基色满、氨基硫代色满及氨基-1,2,3,4-四氢喹啉衍生物，包含其的药物组合物及其在治疗中的用途
|
|
EP3057958B1
(en)
|
2013-10-17 |
2019-05-01 |
AbbVie Deutschland GmbH & Co. KG |
Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
US9550754B2
(en)
|
2014-09-11 |
2017-01-24 |
AbbVie Deutschland GmbH & Co. KG |
4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy
|
|
EP3233799B1
(en)
|
2014-12-19 |
2021-05-19 |
The Broad Institute, Inc. |
Dopamine d2 receptor ligands
|
|
US10633336B2
(en)
|
2014-12-19 |
2020-04-28 |
The Broad Institute, Inc. |
Dopamine D2 receptor ligands
|
|
WO2016112036A1
(en)
|
2015-01-05 |
2016-07-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Myc g-quadruplex stabilizing small molecules and their use
|
|
CN109574993B
(zh)
|
2017-09-29 |
2020-12-18 |
广东东阳光药业有限公司 |
取代的嘧啶哌嗪化合物及其用途
|
|
WO2019131902A1
(ja)
|
2017-12-27 |
2019-07-04 |
武田薬品工業株式会社 |
腹圧性尿失禁および便失禁の治療薬
|
|
CN112851641B
(zh)
*
|
2019-11-28 |
2023-08-15 |
广东东阳光药业股份有限公司 |
嘧啶苯甲酰胺化合物的盐酸盐及其用途
|